Back to Search Start Over

Supplementary Data from The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Authors :
Toni K. Choueiri
Darren Feldman
Robert J. Motzer
Sabina Signoretti
Lauren C. Harshman
James J. Hsieh
Jae Lyun Lee
Sumanta K. Pal
JoAnn Hsu
Fabio A. Schutz
Andre P. Fay
Daniel Y. Heng
J. Connor Wells
Guillermo De Velasco
Daniel Castellano
Eliezer Van Allen
David A. Braun
Xiao X. Wei
Dylan J. Martini
Aly-Khan A. Lalani
Raphael Brandao
Abdallah Flaifel
Stephanie A.M. Wankowicz
Wanling Xie
Dominick Bossé
Rana R. McKay
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Includes: Table 1S. Baseline patient and disease characteristics. Table 2S. Tumor mutation burden status. Table 3S. PDL1 expression data. Figure 1S. Overall survival for the total cohort.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....050a1b150ce3998dd89220d1a3afb6e9
Full Text :
https://doi.org/10.1158/2326-6066.22539886.v1